Overview
Practical Solutions to Prevent and Prepare for Severe Hypoglycemia
Click the"View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
Episodes of hypoglycemia, including those that are severe, still occur despite new pharmacotherapies and the increased use of continuous glucose monitoring. Do you know which of your patients are at risk? Are they prepared with an active glucagon prescription? This activity helps you identify at risk patients and ensure they are prepared with access to glucagon. Included with the education are tools to educate patients and establish processes to improve hypoglycemia recognition and success with glucagon administration.
This activity is intended for the multispecialty clinical team across physicians, nurses, nurse practitioners, physician assistants, pharmacists, and other healthcare providers who manage patients with diabetes and play a role in helping patients prevent and/or prepare for a severe hypoglycemic event.
Hypoglycemia is a common complication of treatment that negatively impacts quality of life and elicits fears in patients with diabetes. Severe episodes, in which the person requires assistance from others, can have negative health consequences such as increased mortality. Identifying patients who are at risk for severe episodes and making sure they and their caregivers are prepared can improve outcomes. Yet, many patients are not prepared, and guideline-recommended glucagon is under prescribed in eligible patients.
Upon completion of this activity, participants will be able to:
• Identify patient-level predictors of severe hypoglycemia and related morbidity
• Discuss the barriers to recognizing and treating severe hypoglycemia
• Utilize strategies to increase and optimize the prevention and preparedness for severe hypoglycemia
• Implement patient education approaches to improve success rates for glucagon administration for severe hypoglycemic events
• Identify patient-level predictors of severe hypoglycemia and related morbidity
• Discuss the barriers to recognizing and treating severe hypoglycemia
• Utilize strategies to increase and optimize the prevention and preparedness for severe hypoglycemia
• Implement patient education approaches to improve success rates for glucagon administration for severe hypoglycemic events
Didactic Module
Recognizing Hypoglycemia
Hypoglycemia Fear and Unawareness
Clinical Surveillance and Management
Recognizing Hypoglycemia
Hypoglycemia Fear and Unawareness
Clinical Surveillance and Management
Case-based Discussion
Case 1: Recently diagnosed patient with type 2 diabetes
Case 2: Patient with 22-year history of type 2 diabetes
Sponsored by Purdue University College of Pharmacy, in partnership with the Academy for Continued Healthcare Learning (ACHL).
This activity is supported by an educational grant from Lilly.
1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
7. Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
7. Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
Davida F. Kruger, MSN, APN-BC, BC-ADM
Certified Nurse Practitioner
Henry Ford Health System
Division of Endocrinology, Diabetes, Bone and Mineral Disease
Detroit, MI
Certified Nurse Practitioner
Henry Ford Health System
Division of Endocrinology, Diabetes, Bone and Mineral Disease
Detroit, MI
Anne Louise Peters, MD
Professor of Clinical Medicine
Keck School of Medicine of USC
Los Angeles, CA
To ensure compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Purdue University requires that all individuals in a position to control the content of an educational activity disclose all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflicts of interest identified are thoroughly assessed by Purdue University to ensure fair balance, scientific rigor, and accepted patient care recommendations of the educational activity.
The following financial relationships have been provided:
Davida F. Kruger, MSN, APN-BC, BC-ADM
Consultant: Abbott, Cequr, Modular Medical, Novo Nordisk, Sanofi
Research Support: Abbott, Beta Bionics, Dexcom, Novo Nordisk,
Speaker: Cequr, Dexcom, Lilly, Novo Nordisk, Sanofi, Xeris
Stock: Pendulum
Anne Louise Peters, MD
Advisory Board: Abbott Diabetes Care, Astra Zeneca, Eli Lilly, Novo Nordisk, Zealand
Research Support: Abbott Diabetes Care, Dexcom, Insulet
Stock/Stock Options: Omada Health, Teladoc
All relevant conflicts of interest have been mitigated prior to the start of the activity.
None of the planners, reviewers, ACHL, and Purdue University College of Pharmacy staff have relevant financial relationship(s) with ineligible companies to disclose unless listed below.
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None
Purdue University College of Pharmacy, ACHL staff members, and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.
This educational activity was planned and produced in accordance with the ACCME and ACPE Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. Purdue University College of Pharmacy requires the speaker to disclose that a product is not labeled for the use under discussion.
This activity will take approximately 60 minutes to complete. To receive credit, participants are required to complete the pretest, view the online activity and complete the posttest and evaluation. To receive credit, 75% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
For questions, contact Laurie Novoryta at lnovoryta@achlcme.org.
CPE/ABIM credit will be submitted to CPE Monitor®/ABIM within 30 days of completion.
Purdue University College of Pharmacy designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.
By providing your ABIM Diplomate number, you consent to have ACHL and/or our educational partners submit your participation in this activity to the ABIM through the ACCME PARS system.
Completion of this activity, including the pretest, posttest, and follow-up assessments, qualifies as a medium weight MIPS improvement activity under MACRA and can be claimed as completion of IA_PSPA 28 of an Accredited Safety or Quality Improvement Program in the Quality Payment Program. Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website. You will receive additional information after completing the activity and receiving your certificate via email.
Purdue University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a knowledge based, continuing education activity of Purdue University, an equal access/equal opportunity institution.
This activity has been approved for 1.0 contact hour.
ACPE Universal Activity Number: 0018-9999-22-023-H01-P
Activity Type(s): Application
Release Date: September 9, 2022
Expiration Date: September 9, 2023
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. Approval is valid from 9/9/2022 to 9/9/2023. AAPA reference number: CME-207877.
ANCC
Purdue University Continuing Nursing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This program is approved for 1.0 contact hour.
This activity is approved for 1.12 contact hour(s) of continuing education (which includes 0.56 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 22085703 This activity was planned in accordance with AANP Accreditation Standards and Policies.
